-
Icotinib Hydrochloride
- names:
Icotinib Hydrochloride
- CAS号:
1204313-51-8
MDL Number: - MF(分子式): C22H22ClN3O4 MW(分子量): 427.88
- EINECS: Reaxys Number:
- Pubchem ID: Brand:BIOFOUNT
| 货品编码 | 规格 | 纯度 | 价格 (¥) | 现价(¥) | 特价(¥) | 库存描述 | 数量 | 总计 (¥) |
|---|
| 中文别名 | |
| 英文别名 | Icotinib Hydrochloride |
| CAS号 | 1204313-51-8 |
| Inchi | |
| InchiKey | |
| 分子式 Formula | C22H22ClN3O4 |
| 分子量 Molecular Weight | 427.88 |
| 溶解度Solubility | 生物体外In Vitro:DMSO溶解度25 mg/mL(58.43 mM;Need ultrasonic) |
| 性状 | |
| 储藏条件 Storage conditions | 粉末Powder: -20°C 3 years年 4°C 2 years年 / In solvent溶液中:-80°C 6 months月 -20°C 1 month月 |
| 产品说明 | |
| Introduction | Icotinib Hydrochloride (BPI-2009) is a potent and specificEGFRinhibitor with anIC50of 5 nM; also inhibits mutant EGFRL858R, EGFRL858R/T790M, EGFRT790Mand EGFRL861Q. |
| Application1 | |
| Application2 | |
| Application3 |
Icotinib Hydrochloride (BPI-2009)为有效,选择性的EGFR抑制剂,IC50值为5 nM;也抑制突变型EGFRL858R,EGFRL858R/T790M,EGFRT790M和 EGFRL861Q。Icotinib Hydrochloride (BPI-2009) is a potent and specificEGFRinhibitor with anIC50of 5 nM; also inhibits mutant EGFRL858R, EGFRL858R/T790M, EGFRT790Mand EGFRL861Q.
| 【1】.Tan F, et al. Icotinib (BPI-2009H), a novel EGFR tyrosine kinase inhibitor, displays potent efficacy in preclinical studies. Lung Cancer. 2012 May;76(2):177-82. |
对不起,暂无产品评价!
MSDS
SDS 1.0 中文
展开
SDS 1.0 英文
展开
- 相关产品
-
< >
- 推荐产品
-
< >
- 最新产品
-
< >
新闻
抱歉,暂无数据!


购物车 


